A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors (ILUMINET)
This study is currently recruiting participants.
Verified April 2013 by Lund University Hospital
Study NCT01456078
Information provided by Lund University Hospital
First Received on October 7, 2011.
Last Updated on April 19, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
